Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer. The company is currently conducting Phase 1 clinical research in patients with advanced cancer to assess the safety, pharmacokinetics, and anti-tumor effectiveness of TACH101. The programs will be advanced in a timely, innovative, high-quality, andscientifically sound manner.

Biotechnology

Health Care

Tachyon Therapeutics

Chandtip Chandhasin

Tachyon Therapeutics

Org chart

Teams

Offices

Similar companies